Usana Health Sciences, Inc. operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Usana Health Sciences with three other
pharmaceutical manufacturers in North America:
Impax Laboratories, Inc.
sales of $860.47 million
of which 83%
was Impax Generics),
Biomarin Pharmaceutical Inc
of which 34%
was Naglazyme), and
of which 100%
was Medical Technologies).
During the year ended December of 2015, sales at
Usana Health Sciences were $918.50 million.
increase of 16.2%
versus 2014, when the company's sales were $790.47 million.
This was the fifth consecutive year of sales increases at Usana Health Sciences
(and since 2010, sales have increased a total of 77%).